Zobrazeno 51 - 60
of 67
pro vyhledávání: '"Peter A. W. te Boekhorst"'
Autor:
Lennart Nilsson, Agnes Guerci-Bresler, Tommy Fu, Carlo Aul, Guillermo Sanz, Dominik Selleslag, Bruno Quesnel, Michael Lübbert, Peter A. W. te Boekhorst, Mario Cazzola, Consuelo del Cañizo, John Francis, Moshe Mittelman, Eva Hellström-Lindberg, Aristoteles Giagounidis, Arnold Ganser, David G. Bowen, Brigitte Schlegelberger, Odile Beyne-Rauzy, Robert Knight, Uwe Platzbecker, Petra Muus, Ghulam J. Mufti, Pierre Fenaux
Publikováno v:
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood, 118(14), 3765-3776. American Society of Hematology
Blood, 118, 14, pp. 3765-76
Blood, 118, 3765-76
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood, 118(14), 3765-3776. American Society of Hematology
Blood, 118, 14, pp. 3765-76
Blood, 118, 3765-76
This phase 3, randomized, double-blind study assessed the efficacy and safety of lenalidomide in 205 red blood cell (RBC) transfusion-dependent patients with International Prognostic Scoring System Low-/Intermediate-1-risk del5q31 myelodysplastic syn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab349b42ac256e110ae756563c3aca76
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16281
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16281
Autor:
Okke de Weerdt, Marleen Luten, René van der Griend, Anneke Brand, Ronnie van der Holt, Peter A. W. te Boekhorst, Jaap Jan Zwaginga, Sonja Zweegman, Art Vreughdenhil, Elisabeth C. M. Van Pampus, Bart J. Biemond, P. C. Huijgens, Mark Levin, Harry R. Koene, Rene Hollestein, Hans Pruijt
Publikováno v:
Blood, 116(21), 1042-1042
Zwaginga, J J, van der Holt, R, Biemond, B J, Boekhorst, P A W, Levin, M, Vreughdenhil, A, Huijgens, P C, Brand, A, van der Griend, R, Luten, M, Pruijt, H, de Weerdt, O, van Pampus, E, Zweegman, S, Hollestein, R & Koene, H R 2010, ' Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients: ' . < http://www.mendeley.com/research/interim-analysis-dutch-hovon-multicenter-randomized-open-label-phase-ii-trial-3-rituximab-dosing-sch >
Zwaginga, J J, van der Holt, R, Biemond, B J, Boekhorst, P A W, Levin, M, Vreughdenhil, A, Huijgens, P C, Brand, A, van der Griend, R, Luten, M, Pruijt, H, de Weerdt, O, van Pampus, E, Zweegman, S, Hollestein, R & Koene, H R 2010, ' Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients: ' . < http://www.mendeley.com/research/interim-analysis-dutch-hovon-multicenter-randomized-open-label-phase-ii-trial-3-rituximab-dosing-sch >
Abstract 2514 The overall short term effectivity of Rituximab in the treatment of ITP is reported to be around 50%. In most studies the traditional CD20 dosing scheme of 4 weekly interspaced 375 mg/m2 doses is used although other single-arm studies s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91342096607e19be0be834be6df27b24
http://hdl.handle.net/1887/118378
http://hdl.handle.net/1887/118378
Autor:
Jean-Louis H, Kerkhoffs, Wim L J, van Putten, Viera M J, Novotny, Peter A W, Te Boekhorst, Martin R, Schipperus, Jaap Jan, Zwaginga, Lizzy C M, van Pampus, Georgine E, de Greef, Marleen, Luten, Peter C, Huijgens, Anneke, Brand, Dick J, van Rhenen
Publikováno v:
British journal of haematology. 150(2)
Pathogen reduction (PR) of platelet products increases costs and available clinical studies are equivocal with respect to clinical and haemostatic effectiveness. We conducted a multicentre, open-label, randomized, non-inferiority trial comparing the
Autor:
Jaap Jan Zwaginga, Peter C. Huijgens, Viera M.J. Novotny, Jean-Louis H. Kerkhoffs, Georgine E. de Greef, Peter A. W. te Boekhorst, Dick J. van Rhenen, Lizzy C.M. van Pampus, Martin R. Schipperus, Anneke Brand, Wim L.J. van Putten, Marleen Luten
Publikováno v:
British Journal of Haematology.
Pathogen reduction (PR) of platelet products increases costs and available clinical studies are equivocal with respect to clinical and haemostatic effectiveness. We conducted a multicentre, open-label, randomized, non-inferiority trial comparing the
Autor:
Heinz Gisslinger, Viktoriya Stalbovskaya, Peter A. W. te Boekhorst, Claire N. Harrison, Prashanth Gopalakrishna, Edric Atienza, Alessandro M. Vannucchi, Dietger Niederwieser
Publikováno v:
Blood. 124:1841-1841
BACKGROUND: Ruxolitinib (RUX) is a potent JAK1/JAK2 inhibitor that has demonstrated superiority over traditional therapies in the treatment of MF. In the 2 phase 3 COMFORT studies, RUX demonstrated rapid and durable reductions in splenomegaly, improv
Autor:
Ruben A. Mesa, Francesco Passamonti, Francisco Cervantes, Sonja Zweegman, S. Slot, Giovanni Barosi, Dana Ranta, Peter A. W. te Boekhorst, Konstanze Döhner, Andreas Reiter, Zhijian Xiao, Gunnar Birgegård, Keith Cannon, Jean-Christophe Ianotto, Jean-Jacques Kiladjian, Maria Grazia Ferrari, Junqing Xu, Claire N. Harrison, Françoise Boyer, Tiziano Barbui, Alessandro Rambaldi, Zefeng Xu, Lydia Roy, Deepti Radia, Jan Samuelsson, Robyn M. Scherber, Jean-Yves Cahn, Frank Stegelmann, Dolores Hernández-Maraver, Bjorn Andreasson, Norman Maldonado, Peter L. Johansson, Amylou C. Dueck, Martin Griesshammer, Holly L. Geyer, Harry C. Schouten, Yue Zhang, Karin Bonatz, Pablo J. Muxi, Thomas Lehmann, Peihong Zhang, Federico Sackman, Xiujuan Sun, Carlos Besses, Ana Kerguelen Fuentes, Gabriel Etienne, Alessandro M. Vannucchi, Heike L. Pahl
Publikováno v:
Blood. 124:1848-1848
Background Polycythemia vera (PV) is a clonal myeloproliferative disorder characterized by erythrocytosis, splenomegaly and a frequently burdensome symptom profile. Despite current guidelines of aspirin, phlebotomy, and selective cytoreduction, many
Autor:
Peter A. W. te Boekhorst, Senada Koljenović, Roos S van Rijn, Theo de Witte, Sandra van Bijnen, Petra Muus
Publikováno v:
British Journal of Haematology, 157, 6, pp. 762-3
British Journal of Haematology, 157, 762-3
British Journal of Haematology, 157(6), 762-763. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 157, 762-3
British Journal of Haematology, 157(6), 762-763. Wiley-Blackwell Publishing Ltd
Item does not contain fulltext 01 juni 2012
Publikováno v:
New England Journal of Medicine. 365:2240-2241
To the Editor: In response to the review by Imbach and Crowther (Aug. 25 issue)1 of thrombopoietin-receptor agonists for primary immune thrombocytopenia: we would like to draw attention to the fact...
Autor:
Carlos Besses, Dana Ranta, Martin Griesshammer, Deepti Radia, Karin Bonatz, S. Slot, Francesco Passamonti, Maria Grazia Ferrari, Francisco Cervantes, Peter Johansson, Amylou C. Dueck, Pablo J. Muxi, Holly L. Geyer, Bjorn Andreasson, Suzan Commandeur, Gabriel Etienne, D. Hernández, Zefeng Xu, Peter A. W. te Boekhorst, Alessandro M. Vannucchi, Zhijian Xiao, Lydia Roy, Ruben A. Mesa, Sonja Zweegman, Harry C. Schouten, Alessandro Rambaldi, Françoise Boyer, Heike L. Pahl, Federico Sackmann, Junqing Xu, Andreas Reiter, Xiujuan Sun, Norman Maldonado, Jean-Christophe Ianotto, Ana Kerguelen Fuentes, Jean-Jacques Kiladjian, Robert Peter Gale, Tiziano Barbui, Ayalew Tefferi, Giovanni Barosi, Frank Stegelmann, Gunnar Birgegård, Thomas Lehmann, Konstanze Doehner, Jean-Yves Cahn, Robyn M. Emanuel, Jan Samuelsson, Yue Zhang, Claire N. Harrison, Peihong Zhang
Publikováno v:
Blood. 122:4067-4067
Background We have previously reported on the significant, but heterogeneous baseline MPN symptom burden among an international sample of MPN patients (including essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF)) utilizin
Autor:
Deepti Radia, Maria Grazia Ferrari, Zefeng Xu, Robyn M. Emanuel, Lydia Roy, Dolores Hernández-Maraver, Amylou C. Dueck, Ruben A. Mesa, Carlos Besses, Holly L. Geyer, Francisco Cervantes, Jan Samuelsson, Claire N. Harrison, Pablo J. Muxi, Jean-Jacques Kiladjian, Keith Cannon, Jean-Yves Cahn, Konstanze Döhner, Françoise Boyer, Thomas Lehmann, Frank Stegelmann, Heike L. Pahl, Bjorn Andreasson, Francesco Passamonti, Peter A. W. te Boekhorst, Zhijian Xiao, Harry C. Schouten, S. Slot, Martin Griesshammer, Alessandro M. Vannucchi, Norman Maldonado, Peihong Zhang, Alessandro Rambaldi, Xiujuan Sun, Robert Peter Gale, Dana Ranta, Ana Kerguelen Fuentes, Andreas Reiter, Jean-Christophe Ianotto, Gabriel Etienne, Tiziano Barbui, Giovanni Barosi, Junqing Xu, Karin Bonatz, Peter Johansson, Sonja Zweegman, Suzan Commandeur, Yue Zhang, Gunnar Birgegård, Federico Sackmann
Publikováno v:
Blood. 122:4087-4087
Background We have previously reported on the high prevalence and severity of insomnia amongst a large international cohort of MPN patients (Emanuel JCO 2012). We sought to further analyze the relationships between insomnia and the MPN disease featur